Dr. David C. Khan is a board certified Radiation Oncologist with special interest and expertise in prostate and breast cancer. He has expertise in Intensity Modulated Radiotherapy (IMRT), Image Guided Radiotherapy (IGRT), Stereotactic Body Radiotherapy, Low Dose Rate brachytherapy, and High Dose Rate (HDR) brachytherapy. His practice is based out of the Los Angeles Cancer Institute and Santa Monica Cancer Treatment Center.

Dr. Khan received his undergraduate degree from Pomona College where he earned the distinction of being a Pomona Scholar. He received his medical degree from Oregon Health Sciences University and then completed his medical training at New York University and Bellevue Hospital, one of the nation’s oldest and most prestigious teaching hospitals. Dr. Khan began his career at Kaiser Permanente in Los Angeles and was quickly promoted the Chief of the Prostate brachytherapy service where he trained resident radiation oncologists in advanced brachytherapy techniques. He has personally performed over 700 prostate seed implants. In addition to his extensive prostate brachytherapy experience, Dr. Khan is an expert in accelerated partial breast irradiation (using the MammoSite®, Contura®, and Savi® brachytherapy devices). Dr. Khan was also one of the first physicians in Southern California to utilize the Calypso® 4D localization system, which utilizes tiny electromagnetic transponders to accurately localize and track tumors both before and during treatment delivery. He has published on both prostate and breast brachytherapy.

Dr. Khan is a managing partner of Cancer Care Consultants Medical Associates and is the Medical Director at Los Angeles Cancer Institute and Santa Monica Cancer Treatment Center. He also serves on the Emerging Technologies Committee for the American Society of Therapeutic Radiation Oncology (ASTRO). In recognition of his superior clinical acumen and compassionate bedside manner, Dr. Khan has been repeatedly selected to be one of the Best Doctors in America as well one of America’s Top Oncologists.